Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
American Journal of Respiratory and Critical Care Medicine|January 16, 2010
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesotheliomaKevin Hollevoet, Kristiaan Nackaerts, Joël Thimpont, et al.Plos One|September 21, 2011
Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic reviewIsabelle Cleynen, Peter Jüni, Geertruida E Bekkering, et al.Breast Cancer Research and Treatment|February 25, 2009
Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of LimburgPatrik Vankrunkelsven, Eliane Kellen, Daniël Lousbergh, et al.Cancer Research Communications|January 21, 2025
Age at First Full-term Pregnancy and Other Reproductive Factors Are Associated with Mammographic Breast Density in Postmenopausal Women: A Study in Flanders, BelgiumMagda J Vandeloo, Eliane Kellen, Carolyn Y Fang, et al.Chest|July 9, 2011
The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factorKevin Hollevoet, Kristiaan Nackaerts, Olivier Thas, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 16, 2011
Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesotheliomaKevin Hollevoet, Kristiaan Nackaerts, Robert Gosselin, et al.Cancer Epidemiology|January 6, 2023
The effect of the Flemish breast cancer screening program on breast cancer-specific mortality: A case-referent studyKatrien De Troeyer, Geert Silversmit, Michael Rosskamp, et al.European Radiology|May 22, 2013
Technical and clinical breast cancer screening performance indicators for computed radiography versus direct digital radiographyHilde Bosmans, An De Hauwere, Kim Lemmens, et al.American Journal of Epidemiology|April 4, 2007
Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC reviewEliane Kellen, Marjolein Hemelt, Karin Broberg, et al.BMC Urology|March 23, 2012
Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in BelgiumMaria E Goossens, Frank Buntinx, Steven Joniau, et al.Pageof 6